MERAVIGLIA, Serena
 Distribuzione geografica
Continente #
NA - Nord America 9.237
EU - Europa 5.547
AS - Asia 4.625
SA - Sud America 727
AF - Africa 140
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.304
Nazione #
US - Stati Uniti d'America 9.055
SG - Singapore 1.676
RU - Federazione Russa 1.457
IT - Italia 1.333
CN - Cina 1.185
FI - Finlandia 586
BR - Brasile 566
HK - Hong Kong 503
DE - Germania 478
UA - Ucraina 414
VN - Vietnam 404
PL - Polonia 283
GB - Regno Unito 254
FR - Francia 204
JP - Giappone 178
IE - Irlanda 153
IN - India 125
SE - Svezia 110
BD - Bangladesh 104
CA - Canada 100
KR - Corea 93
NL - Olanda 64
AR - Argentina 54
AT - Austria 48
TR - Turchia 47
MX - Messico 46
IQ - Iraq 45
CI - Costa d'Avorio 42
IR - Iran 37
BE - Belgio 33
PK - Pakistan 33
UZ - Uzbekistan 33
ES - Italia 30
RO - Romania 30
ZA - Sudafrica 28
CL - Cile 21
VE - Venezuela 21
SA - Arabia Saudita 20
AU - Australia 19
MA - Marocco 18
CO - Colombia 17
PH - Filippine 17
ID - Indonesia 16
NP - Nepal 15
JO - Giordania 13
KE - Kenya 13
PY - Paraguay 13
EC - Ecuador 12
CR - Costa Rica 11
RS - Serbia 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
MY - Malesia 10
BO - Bolivia 9
DZ - Algeria 9
EG - Egitto 7
KZ - Kazakistan 7
OM - Oman 7
TN - Tunisia 7
UY - Uruguay 7
AZ - Azerbaigian 6
BY - Bielorussia 6
GR - Grecia 6
JM - Giamaica 6
PE - Perù 6
TH - Thailandia 6
AL - Albania 5
KG - Kirghizistan 5
PA - Panama 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EU - Europa 4
IL - Israele 4
LB - Libano 4
LT - Lituania 4
NG - Nigeria 4
SN - Senegal 4
BB - Barbados 3
BG - Bulgaria 3
BH - Bahrain 3
GE - Georgia 3
HU - Ungheria 3
MK - Macedonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TW - Taiwan 3
AM - Armenia 2
ET - Etiopia 2
HN - Honduras 2
KH - Cambogia 2
MD - Moldavia 2
MM - Myanmar 2
NI - Nicaragua 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TG - Togo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
Totale 20.291
Città #
Singapore 1.147
Ashburn 1.103
Fairfield 810
Chandler 602
Hong Kong 482
Woodbridge 478
San Jose 476
Houston 433
Ann Arbor 408
Palermo 360
Wilmington 323
Seattle 316
Moscow 265
Zgierz 237
Jacksonville 225
Cambridge 222
Des Moines 211
Beijing 193
Los Angeles 185
Council Bluffs 172
Tokyo 167
New York 159
Dublin 153
Santa Clara 152
Dallas 145
Medford 145
The Dalles 133
Ho Chi Minh City 123
Lauterbourg 109
Hanoi 108
Milan 104
Frankfurt am Main 102
Hefei 96
Princeton 91
Altamura 87
Helsinki 87
Nanjing 82
Boardman 78
Chicago 69
Lawrence 66
Buffalo 64
Rome 59
Tulsa 58
San Diego 57
Dearborn 56
London 48
Ludwigshafen am Rhein 44
Orem 43
São Paulo 43
Abidjan 41
Munich 41
Warsaw 41
Amsterdam 37
Montreal 35
Brussels 33
Nanchang 32
Tianjin 32
Denver 31
Jinan 30
Phoenix 30
Shenyang 30
Guangzhou 29
Seoul 29
Venice 29
Piscataway 27
Atlanta 25
Changsha 25
Nuremberg 25
Stockholm 25
Bremen 24
Jiaxing 24
Tashkent 24
Brooklyn 23
Hebei 23
Columbus 22
Da Nang 22
Johannesburg 22
Kumar 22
Vienna 22
Ottawa 21
Salt Lake City 21
Turku 21
Poplar 20
Tehran 20
Shanghai 19
Paris 18
Rio de Janeiro 18
Baghdad 17
Lappeenranta 17
Washington 17
Chennai 16
Falls Church 16
Naples 16
Seongnam 16
Boston 15
Catania 15
Mumbai 15
Toronto 15
Turin 15
Zhengzhou 15
Totale 12.594
Nome #
IL4 primes the dynamics of breast cancer progression via DUSP4 inhibition 343
γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion 336
Characterization of human infiltrating and circulating gamma-delta t cells in prostate cancer 300
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas 298
Squamous cell tumors recruit γδ T cells producing either IL17 or IFNγ depending on the tumor stage 297
Distinctive features of tumor-infiltrating gd T lymphocytes in human colorectal cancer 284
Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection 283
LEMON-DERIVED EXTRACELLULAR VESICLES EXERT ANTI-INFLAMMATORY EFFECTS BY INHIBITING THE ERK/NF-KB PATHWAY 281
Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome 255
Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis 241
Aminobisphosphonate-activated gammadelta T cells in immunotherapy of cancer: doubts no more. 236
Immunotherapy targeting colon cancer stem cells 234
Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes 233
Analysis of colon-infiltrating γδ T cells in chronic inflammatory bowel disease and in colitis-associated cancer 232
Reciprocal stimulation of gammadelta T cells and dendritic cells during the anti-mycobacterial immune response 230
An overview of the role of T cells in controlling tuberculosis infection in a pediatric population 229
Characterization of γδ T cells in intestinal mucosa from patients with early onset or long standing inflammatory bowel disease and their correlation with clinical status 227
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells 220
Decreased serum granulysin levels in childhood tuberculosis whinch reverse after therapy 217
Γ δ T Cell-Based Immunotherapy in Melanoma: State of the Art 215
Differentiation, phenotype, and function of interleukin-17-producing human V{gamma}9V{delta}2 T cells 214
Anti-inflammatory properties of lemon-derived extracellular vesicles are achieved through the inhibition of ERK/NF-κB signalling pathways 209
Differentiation of human CD8+ T cells in BCG vaccinated and tuberculous patients. 209
Mechanisms underlying lineage commitment and plasticity of human γδ T cells. 207
Immunomodulation in vascularized composite allotransplantation: What is the role for adipose-derived stem cells? 206
A SUBSET OF VGAMMA9 VDELTA2 T CELLS HELP B CELLS FOR ANTIBODY PRODUCTION. 205
V{gamma}9V{delta}2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells. 205
γδ T cells as a potential tool in colon cancer immunotherapy 204
Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens. 203
Current Advances in γδ T Cell-Based Tumor Immunotherapy 203
Vg9Vd2 T cells as a promising innovative tool for immunotherapy of hematologic malignancies 202
Aminobisphosphonates as New Weapons for gammaDelta T Cell-Based Immunotherapy of Cancer 201
A risk score derived from the analysis of a cluster of 27 serum inflammatory cytokines to predict long term outcome in patients with acute myocardial infarction: A pilot study 200
Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes 198
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. 197
Cell Mediated Immune System Hyperactivation and Complications in Surgery. Is There a Correlation? 197
Cell quality evaluation with gene expression analysis of spheroids (3D) and adherent (2D) adipose stem cells 193
Metabolic changes in tumor microenvironment: How could they affect γδ t cells functions? 192
Ferritin Metabolism Reflects Multiple Myeloma Microenvironment and Predicts Patient Outcome 190
CXCR5 identifies a subset of Vgamma9 Vdelta2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production. 188
γδ cells and tumor microenvironment: A helpful or a dangerous liason? 188
Tuning inflammation in tuberculosis: the role of decoy receptors 188
Immune Cells, Cytokines, and Gut Microbiota Landscape Along Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma (MM) Evolution 184
Immunomodulating role of bisphosphonates on human gamma delta T cells: an intriguing and promising aspect of their antitumour activity. 184
Cross-talk between gamma delta T cells and dendritic cells in anti-mycobacterial immune response 184
Prevention of the post-chemotherapy relapse of tuberculous infection by combined immunotherapy. 184
Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection. 184
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. 183
Activation of human V gamma9 V delta 2 T cells by plasmacytoid dendritic cells 182
New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response 182
T-Cell Subsets (TCM, TEM, TEMRA) and Poly-Functional Immune Response in Patients with Human Immunodeficiency Virus (HIV) Infection and Different T-CD4 Cell Response 180
γδ cell-based immunotherapy for cancer. 178
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer 176
Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again 175
Heterogeneity and prognostic influence of tumor- infiltrating γδ T lymphocytes in colon cancer patients 174
Partial and Ineffective Activation of V{gamma}9V{delta}2 T Cells by Mycobacterium tuberculosis-Infected Dendritic Cells 173
Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vγ9Vδ2 T Cell-Mediated Cytotoxicity 173
HUMAN MEMORY VGAMMA9 VDELTA2 T CELLS REQUIRE HOMEOSTATIC CYTOKINES FOR PROLIFERATION AND DIFFERENTIATION. 172
A novel ELISA system for detecting serum granulysin in tuberculosis patients 172
In vitro effects of aminobisphosphonates on Vgamma9Vdelta2 T cell activation and differentiation. 169
Advances in immunotherapy of castration-resistant prostate cancer: Bisphosphonates, phosphoantigens and more. 169
gd T cells condition dendritic cells in vivo for priming pulmonary CD8 T cell responses against Mycobacterium tuberculosis 168
Memory and effector CD8 T cell subset in human tuberculosis. 167
Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment 166
Effects of the static magnetic field generated by a 1,5 T MRI unit on TNF-a release and TNF-receptor II expression of human monocyes 165
EFFECTS OF THE STATIC MAGNETIC FIELD GENERATED BY A 1.5 T MRI UNIT ON TNF ALFA RELEASE AND TNF RECEPTOR II EXPRESSION OF HUMAN MONOCYTES. 165
An analysis of the immunomodulatory properties of human spheroids from adipose-derived stem cells 164
Characterization of HLA-DR- and TCR-binding residues of an immunodominant and genetically permissive peptide of the 16-kDa protein of Mycobacterium tuberculosis 163
Characterisation of γδ T cells infiltrating colorectal cancer 163
Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vgamma9Vdelta2 naive, memory and effector T cell subsets. 161
Activation and selective IL-17 response of human Vγ9Vδ2 T lymphocytes by TLR-activated plasmacytoid dendritic cells 161
Cross-talk between human myeloid dendritic cells and VG9VD2 T cells during M. tuberculosis infection. 160
Memory and effector CD8 T cell subsets in human tuberculosis. 159
Distribution, function and predictive value of tumor-infiltrating γδ T lymphocytes 158
Optimizing Tumor-Reactive γδ T Cells for Antibody-Based Cancer Immunotherapy 156
Nivolumab in metastatic melanoma: good efficacy and tolerability in elderly patients 154
Sicilian semi- and supercentenarians: identification of age-related T-cell immunophenotype to define longevity trait 149
Integrated Multi-Omic Profiling of Immune, Soluble, and Microbial Signatures Identifies Predictors of Multiple Myeloma Evolution 149
Clonal expansion shapes the human Vδ1T cell receptor repertoire. 149
The expanding universe of gamma delta T lymphocytes: subsets, generation and function 148
Differentiation of human Vgamma9 Vdelta 2 T cell subsets by antigen or homeostatic cytokines 146
gammadelta T Cell Modulation in Anticancer Treatment 145
Autologous conditioned serum for chronic pain in patients with osteoarthritis: A feasibility observational study 144
Role of the immune system in amyotrophic lateral sclerosis. Analysis of the natural killer cells and other circulating lymphocytes in a cohort of ALS patients 140
Multi-Omic Profiling of NK Cell Dysfunction and Tumor Immune Escape in Multiple Myeloma Evolution 138
Exosomes released by chronic myelogenous leukemia cells modulate gamma-delta T cell activities 138
ThO to Th1 switch of CD4T cell clones specific from the 16-kDa antigen of Mycobacterium tuberculosis after successfull therapy: lack of involvement of epitope repertoire and HLA-DR 137
Mapping Cell-Cell Communication Dynamics Across the Spectrum of Multiple Myeloma Evolution Using Single-Cell Transcriptomics 134
Tumor-infiltrating γδ T cells as targets of immune checkpoint blockade in melanoma 133
Correlation between tissue-harvesting method and donor-site with the yield of spheroids from adipose-derived stem cells 131
Frequency, phenotype and function of Mycobacterium tuberculosis-specific CD8 T cells in patients with active tuberculosis and in individuals with latent infection 131
Homing and memory patterns of human gamma delta T cells in physiopathological situations 130
Re: Correlation between tissue-harvesting method and donor-site with the yield of spheroids from adipose-derived stem cells 130
Frequency and subset distribution of human CD8 T cells specific for mycobacterial peptides in healthy contact individuals. 129
Unveiling Novel Therapeutic Targets for CAR Therapy in Multiple Myeloma through Single-Cell RNA Sequencing 128
Deciphering human γδ T cell response in cancer: Lessons from tumor-infiltrating γδ T cells 126
Il Complesso Maggiore di Istocompatibilità ed il Rigetto dei Trapianti 125
Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis 122
Deciphering the Interplay of Immune Alterations and Microbiome Changes Along Multiple Myeloma Evolution From Premalignant Conditions 119
High TIM-3 Expression May Contribute to the Functional Impairment of Bone Marrow and Circulating Gamma Delta T Lymphocytes during the Progression of Multiple Myeloma 118
Totale 18.637
Categoria #
all - tutte 70.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.129


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021260 0 0 0 0 0 0 0 0 0 0 129 131
2021/20221.186 40 259 16 47 63 51 66 73 145 154 80 192
2022/20231.873 156 297 21 205 205 265 213 145 209 12 95 50
2023/20241.053 33 126 90 86 50 202 114 92 31 34 24 171
2024/20252.536 66 173 254 195 84 76 223 178 163 301 336 487
2025/20268.643 800 209 477 785 927 1.345 1.180 891 650 1.019 360 0
Totale 20.946